Charles & Colvard (CTHR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Riverstyx Capital Management, a significant shareholder, is soliciting proxies to elect three of its nominees to the board at the upcoming annual meeting scheduled for October 13, 2025.
Riverstyx owns approximately 7.4% of the outstanding common shares as of March 25, 2025, and is challenging a recent dilutive stock issuance by the company.
The proxy contest is in response to concerns about board composition and shareholder value, with Riverstyx seeking to replace three incumbent directors.
The solicitation is not on behalf of the current board or management, and Riverstyx is bearing all solicitation costs, estimated up to $250,000.
Voting matters and shareholder proposals
Proposal 1 seeks to elect Riverstyx’s three nominees—Benjamin O. Franklin IV, Michael R. Levin, and Lloyd M. Sems—to the board for a one-year term expiring at the 2026 annual meeting.
Shareholders may vote for up to three nominees using the BLUE proxy card; only the latest valid proxy submitted will be counted.
Voting is by plurality, and broker non-votes will not affect the outcome.
Shareholders can revoke or change their vote at any time before the meeting by submitting a new proxy or written notice.
Board of directors and corporate governance
The board currently consists of five directors, all elected annually for one-year terms.
If all three Riverstyx nominees are elected, they would constitute a majority of the board.
The nominees are considered independent under SEC rules and have no prior affiliation with the company.
Nominees have significant experience in finance, accounting, investment, audit, and marketing.
Latest events from Charles & Colvard
- Court-ordered annual meeting set for October 13, 2025, with limited agenda and board elections.CTHR
Proxy Filing1 Dec 2025 - Shareholders face a contested Board election and key governance votes amid ongoing financial challenges.CTHR
Proxy Filing1 Dec 2025 - Director nominations by a shareholder were invalidated; Board to recommend elections at the Annual Meeting.CTHR
Proxy Filing1 Dec 2025 - Proxy contest seeks to replace four directors to address financial and governance concerns.CTHR
Proxy Filing1 Dec 2025 - Shareholders face a contested Board election amid calls for leadership change and strategic overhaul.CTHR
Proxy Filing1 Dec 2025 - Board recommends its director slate, annual say-on-pay, and cost-saving measures amid restructuring.CTHR
Proxy Filing1 Dec 2025 - FY2024 saw a 27% sales decline, $14.4M loss, and major liquidity risks for Charles & Colvard.CTHR
Q4 202430 Sep 2025